Navigation Links
Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
Date:4/9/2009

Millennium Bioceutics, announces the release of it's advanced nutritional supplement, Caplex, to cancer patients worldwide. Caplex contains a unique patent pending formulation created by an Oncologist and Clinical Dietitian. Caplex nutrition supplement provides cancer patients a comprehensive source of the most effective anti-tumor nutrients and herbal compounds based on results accumulated from medical research. Impressive changes in the growth rate of prostate cancer has been seen in patients who take Caplex. Caplex provides a well tolerated all-natural treatment option to cancer patients.

Miami, FL (PRWEB) April 9, 2009 -- Millennium Bioceutics, announces the release of it's advanced nutritional supplement, Caplex, to cancer patients worldwide. Caplex contains a unique patent pending formulation created by an Oncologist and a Clinical Dietitian. The supplement to provide cancer patients a comprehensive source of the most effective anti-tumor nutrients and herbal compounds based on results accumulated from medical research.

Caplex contains 9 powerful cancer fighting nutrients including: Purified Capsaicin, Lycopene, Curcumin, Selenium, Vitamin D & E, Zinc and the Omega 3 Fatty Acids, EPA & DHA. Each of these compounds has shown effectiveness in scientific studies as nutrients with powerful antioxidant properties and the ability to slow and or prevent tumor growth. Now researchers are finding that the effectiveness of these nutrients is further enhanced when taken together, demonstrating an important synergistic effect amongst these nutrients. gy" imgurl="http://image.bio-medicine.org/img/Cancer-Fighting-Nutrition-Supplement--Caplex--Offers-Cancer-Patients-A-New-All-Natural-Treatment-Option.gif" timex="4/9/2009 12:37:49 AM" dirsub="(in are further enhanced when taken at th...)" id="11451" index="biology" dir="Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option" dir2="Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatm..." keywords1=",biological,advanced biology technology,biology laboratory technology,biology device technology,latest biology technology" keywords="Cancer,Fighting,Nutrition,Supplement,,Caplex,,Offers,Cancer,Patients,A,New,All-Natural,Treatment,Option" description="in are further enhanced when taken at the same time. "Caplex has ...Caplex offers an all-natural and well-tolerated treatment option for ...Caplex is available in select pharmacies and can now be ordered direc...# # # ...Read the full story at a href http://www.prweb.com/releases/2009/04/..." url=u&"/biology-technology-1/Cancer-Fighting-Nutrition-Supplement--Caplex--Offers-Cancer-Patients-A-New-All-Natural-Treatment-Option-11451-2/" title="Cancer%20Fighting%20Nutrition%20Supplement%2C%20Caplex%2C%20Offers%20Cancer%20Patients%20A%20New%20All-Natural%20Treatment%20Option" %> Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatm... ( Millennium B...)

Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
Date:4/9/2009

Caplex has a unique combination of nutrients that work together synergistically, providing a powerful cancer fighting formula. This gives patients an easier way to get the benefits of all these nutrients in one readily accessible source.

"We have seen impressive changes in the growth rate of prostate cancer in patients who take Caplex and none of the patients taking it have noted significant side effects," says Nancy Matsuura, Clinical Dietitian and Founder of Millennium Bioceutics.

Caplex offers an all-natural and well-tolerated treatment option for cancer patients and prevention regimens. As with all medications and nutritional supplements, patients should talk to their doctors prior to starting any new treatment options.

Caplex is now available online online at http://www.caplexsupplement.com and coming to leading hospitals and research centers throughout the US. Part of the proceeds go towards cancer research.

# # #

Read the full story at http://www.prweb.com/releases/2009/04/prweb2299274.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program
2. Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
3. Groundbreaking Research Begins for Pancreatic and Lung Cancers
4. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
5. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
6. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
7. Nereus Pharmaceuticals Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer
8. Medarex to Present at the Needham Cancer Therapeutics Conference
9. Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer
10. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
11. Samtheo Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Novel Akt Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
(Date:2/10/2016)... DUBLIN , Feb. 10, 2016  Allergan plc ... today announced that Brent Saunders , Allergan,s CEO ... in a fireside chat session at the RBC Capital ... 12:30 p.m. ET at The New York Palace Hotel ... presentation will be webcast live and can be accessed ...
(Date:2/10/2016)... Springfield, MO (PRWEB) , ... February 10, 2016 ... ... company, will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter ... of ISPE is expecting to fill more than 100 tables for its annual ...
(Date:2/10/2016)... ... 10, 2016 , ... PatientCrossroads announces that the ... online PatientCrossroads platform, has exceeded both its one-year and overall recruitment goals since ... which seeks to advance understanding of the hereditary risks for certain kinds of ...
(Date:2/10/2016)... ... ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on the discovery and ... been selected to present at the Cavendish Global Health Impact Forum taking place February ... of the Forum is to help family offices and foundations develop and implement their ...
Breaking Biology Technology:
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Facial ... offering. --> http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has ... Facial Recognition Market 2016-2020" report to ... Markets ( http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the ...
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/3/2016)... , Feb. 3, 2016 Vigilant Solutions ... Police Department in Missouri solved ... plate reader (LPR) data from Vigilant Solutions. ... case in which the victim was walking out of a convenience store and ... space next to his vehicle, striking his vehicle and ...
Breaking Biology News(10 mins):